Key result
Isoprenaline was used as an antiarrhythmic agent in three patients with recurrent ventricular tachycardia and ventricular fibrillation early after cardiac valve replacement.
Why the study?
Does isoprenaline control recurrent ventricular tachycardia and ventricular fibrillation in patients in the early post-operative period after cardiac valve replacement?
Case Report (n=3)
Does isoprenaline control recurrent ventricular tachycardia and ventricular fibrillation in patients in the early post-operative period after cardiac valve replacement?
Isoprenaline, despite being a sympathomimetic, may have utility as an antiarrhythmic agent for recurrent VT/VF early after cardiac valve replacement.
Answers are grounded in this paper and cite their sources.
May support isoprenaline for refractory post-valve VT/VF; leaves open confirmation of safety and efficacy.
The sympathomimetic drugs are generally con- sidered to increase cardiac automaticity, thus predisposing to ventricular ectopic beats, ventricular tachycardia, and ventricular fibrillation (Foster, 1966; Hellerstein, Brofman, and Caskey, 1952). This paper describes the use of isoprenaline, a sympathomimetic drug, as an antiarrhythmic agent in three patients. These patients were having re- current ventricular tachycardia and ventricular fibrillation in the early post-operative period after cardiac valve replacement.
No takes yet. Share an insight, caveat, or question.
Gunning et al. (1969) conducted a case report in Recurrent ventricular tachycardia and ventricular fibrillation after cardiac valve replacement (n=3). Isoprenaline was evaluated. Isoprenaline was used as an antiarrhythmic agent in three patients with recurrent ventricular tachycardia and ventricular fibrillation early after cardiac valve replacement.
Synapse has enriched 10 related papers. Consider them for comparative context: